Form 8-K Medinotec Inc. For: Feb 08
- Wall Street see-saws higher as Fed hints at rate hike pause
- Fed Day: '25bps seems the most likely, and best outcome' - JPMorgan
- U.S. Fed delivers small rate hike amid global banking turmoil
- PacWest says it would not be 'prudent' to go ahead with capital raise
- Meme stocks rally after GameStop posts surprise fourth-quarter profit
Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction of incorporation)||(Commission File Number)||(I.R.S. Employer Identification No.)|
North Riding |
|(Address of principal executive offices)||(Zip Code)|
Registrant’s telephone number, including area code:
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)|
|Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)|
|Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))|
|Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))|
Securities registered pursuant to Section 12(b) of the Act: None.
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant
to Section 13(a) of the Exchange Act.
SECTION 2 – Financial Information
|Item 2.02||Results of Operations and Financial Condition.|
On February 8, 2023, we completed an audit of our consolidated balance sheet as of November 30, 2022 the related consolidated statement of operations, changes in stockholders’ equity and cash flow for the nine months ended November 30, 2022 and the related notes (collectively referred to as the "Financial Statements"). We have delivered the Financial Statements to OTC Markets in connection with our application to quote on the OTCQX tier of OTC Markets.
The Financial Statements are furnished with this Current Report on Form 8-K as Exhibit 99.1. The information furnished under this Item 2.02 and Item 9.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any registration statement or other filing under the Securities Act of 1933, as amended, regardless of any general incorporation by reference language in such filing, except as shall be expressly set forth by specific reference in any such filing.
SECTION 9 – Financial Statements and Exhibits
|Item 9.01||Financial Statements and Exhibits.|
|99.1||Audited Financial Statements|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ Pieter van Niekerk
Pieter van Niekerk
Chief Financial Officer
Date February 8, 2023
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L’OCCITANE en Provence opens new store locations and concepts across Canada
- Enhanced CSX Carbon Calculator Helps Shippers Achieve Sustainability Goals
- The Bone Health & Osteoporosis Foundation Unveils New Patient-Centered Tool for Osteoporosis Prevention and Management
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!